CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 84 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,815,121 | +97.8% | 61,033 | +19.8% | 0.00% | +200.0% |
| Q2 2023 | $917,867 | +8.5% | 50,936 | -3.3% | 0.00% | 0.0% |
| Q1 2023 | $845,655 | -13.9% | 52,656 | -1.9% | 0.00% | -50.0% |
| Q4 2022 | $982,307 | -5.6% | 53,678 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $1,041,000 | +2.8% | 53,010 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $1,013,000 | -4.6% | 54,338 | +12.3% | 0.00% | +100.0% |
| Q1 2022 | $1,062,000 | -28.6% | 48,377 | -7.7% | 0.00% | -50.0% |
| Q4 2021 | $1,488,000 | +82.8% | 52,392 | +35.6% | 0.00% | +100.0% |
| Q3 2021 | $814,000 | -14.2% | 38,650 | -23.2% | 0.00% | 0.0% |
| Q2 2021 | $949,000 | +52.3% | 50,354 | +23.4% | 0.00% | 0.0% |
| Q1 2021 | $623,000 | +8.2% | 40,798 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $576,000 | -9.9% | 40,798 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $639,000 | -10.6% | 40,798 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $715,000 | +182.6% | 40,798 | +137.2% | 0.00% | 0.0% |
| Q1 2020 | $253,000 | -40.7% | 17,197 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $427,000 | +66.8% | 17,000 | 0.0% | 0.00% | – |
| Q3 2019 | $256,000 | -39.8% | 17,000 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $425,000 | +40.3% | 17,000 | +27.7% | 0.00% | 0.0% |
| Q1 2019 | $303,000 | -7.6% | 13,309 | +21.7% | 0.00% | 0.0% |
| Q4 2018 | $328,000 | +8.6% | 10,932 | +3.9% | 0.00% | 0.0% |
| Q3 2018 | $302,000 | – | 10,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $76,819,000 | 7.66% |
| RA Capital Management | 1,875,209 | $42,680,000 | 1.84% |
| Perceptive Advisors | 2,587,953 | $58,901,000 | 1.66% |
| EMORY UNIVERSITY | 97,035 | $2,209,000 | 1.55% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $3,817,000 | 1.05% |
| Orbimed Advisors | 1,914,282 | $43,569,000 | 0.67% |
| Opaleye Management Inc. | 73,000 | $1,661,000 | 0.46% |
| Novo Holdings A/S | 135,009 | $3,073,000 | 0.46% |
| Virtus ETF Advisers LLC | 7,934 | $181,000 | 0.38% |
| Eventide Asset Management | 384,000 | $8,740,000 | 0.30% |